Riskpilot← Back to searchSign inGet full accessNorvesta AB
ABActiveOrg 5593586489Törners Väg 124General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK 1,3M
-1% vs 2024
EBITDA margin
94.7%
0% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
SEK 962K
0% vs 2024
| Revenue | SEK 1,3M | -1% |
| EBITDA | SEK 1,2M | +0% |
| Net profit | SEK 962K | +0% |
| Total assets | SEK 3,9M | +56% |
| Equity | SEK 2,6M | +54% |
| Employees | 0 | — |
Legal name
Norvesta AB
Org number
5593586489
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 januari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsult- och rådgivningstjänster, utbildning och föreläsningar inom psykiatri, ledning, organisation och analys, samt därmed förenlig verksamhet.
Address
Törners Väg 124
Email
victor.lindfors@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 385 | 890 | 1 296 | 1 282 |
| Staff expenses | −3 | −11 | −0 | −0 |
| EBITDA | 337 | 809 | 1 210 | 1 214 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 337 | 809 | 1 210 | 1 214 |
| Net financials | 0 | 1 | −0 | −1 |
| Profit before tax | 337 | 810 | 1 210 | 1 213 |
| Tax | −69 | −167 | −249 | −251 |
| Net profit | 267 | 643 | 961 | 962 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 437 | 1 123 | 2 505 | 3 908 |
| Equity | 292 | 740 | 1 701 | 2 613 |
| Long-term debt | — | — | 190 | 719 |
| Short-term debt | 145 | 383 | 614 | 577 |
| Total debt | 145 | 383 | 804 | 1 296 |
EBITDA margin
94.7%
This company
15.8%
Market median
+499% vs market
20222025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20222025
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
20222025
Net profit margin
75.0%
This company
8.1%
Market median
+826% vs market
20222025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20222025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-04 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Norvesta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Torsten Bjarnesson Lindfors | Board of Directors | 0 companies |
| Victor Karl Lindfors | Board of Directors | 0 companies |
| Adam Otto Karl Lindfors | Deputy Board Member | 0 companies |